Use of ingredients in infant formula for special medical purposes
Taiwan
Sep 30, 2022
The Taiwan Food and Drug Administration (TFDA) consulted on the amendment to the use restriction of 2′-fucosyllactose (2′-FL) produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d (hereinafter referred to as “E. coli K-12 MAP1001d”) and genetically modified Escherichia coli strain BL21 (DE3) #1540 (hereinafter referred to as “E. coli BL21 (DE3) #1540”).
For further information (in Chinese), click on the Link
Update on progress on the review of commercial infant and young child food policy
Australia
Apr 02, 2025
New standard on Canned Baby Foods
Zambia
Apr 01, 2025
FDA Issues Action Levels for Lead in Processed Food for Baby Food
USA
Jan 13, 2025
New requirements for labeling baby foods
Ukraine
Nov 27, 2024
Announces proposal for milk and functional foods for children under 6 years of age subject to price declaration
Vietnam
Sep 12, 2024
New bill in US senate to reduce harmful toxins in baby food
USA
May 09, 2024
OSARTEC extends deadline for comments on new rules for nutrition labeling of children's food
El Salvador
Mar 18, 2024
FSSAI revises Standards for Children's Nutritional Foods
India
Mar 14, 2024
SAMR to require registration of liquid infant formula
China
Jan 24, 2024
Draft amendment to the regulation of foods for special diets and infant foods
Canada
Nov 30, 2023
Guidelines for Online Sales of Special Foods published
China
Oct 23, 2023
New Draft Technical Regulation on cereal-based foods for infants and young children
Paraguay
Jul 07, 2023
Partial Amendment on the Food Labeling Standards
Japan
Jul 03, 2023
2ʹ-fucosyllactose (2ʹ-fucosyllactose): restrictions of use and labeling requirements published by MHW
Taiwan
Jun 08, 2023
Enzymes approved as processing aids
Australia
Feb 20, 2023
